NEUROPEPTIDES--APPROACH TO AMIDATION EFFECTORS
NEUROPEPTIDES--APPROACH TO AMIDATION EFFECTORS
批准号:
2900696
负责人:
SHELDON W MAY
金额:
$21.22万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-02-01 至 2002-03-31
关键词:
amidation /deamidation carboxyl group drug design /synthesis /production enzyme inhibitors enzyme substrate enzyme substrate analog gastrins glycine growth inhibitors lyase neoplastic growth neuroeffector neuropeptides oxygenases posttranslational modifications tissue /cell culture transfection vasomotion
中文摘要
生物活性多肽,其功能是激素、神经递质和
神经调节剂,因此与几乎所有的细胞
函数,已知是从较大的前兆通过
各种各样的翻译后修饰。尤其是羧基
末端酰胺化是生物活性的关键结构特征
在许多生物活性多肽中。现在很清楚,羧基末端
酰胺化需要两个连续的酶促步骤。第一种酶
缩氨酸氨基单加氧酶(PAM)催化形成
甘氨酸扩展前体的α-羟基甘氨酸衍生物。
第二种酶,缩氨酸乙醇酸裂解酶(PGL)-第一
由我们实验室报道的--催化a-脱氢酶-
羟基甘氨酸降解剂,以生产最终的酰胺化产品
乙二醇酯。我们的研究项目集中在这种碳链末端。
酰胺化抑制剂、钝化剂和底物类似物,并描绘
辅助性加工在各种细胞水平的过程中的作用
如血管功能和肿瘤细胞生长。
英文摘要
Bioactive peptides, which function as hormones, neurotransmitters and
neuromodulators, and are thus vitally involved in virtually all cellular
functions, are known to be generated from larger precursors via a
variety of postranslational modifications. In particular, carboxyl
terminus amidation is a key structural feature in the bioligical activity
of many bioactive peptides. It is now clear that carboxyl-terminal
amidation entails two sequential enzymtic steps. The first enzyme
peptidylglycine a-amidating monoxygenase (PAM) catalyzes formation
of the a-hydroxyglycine derivative of the glycine extended precursor.
The second enzyme, peptidylamidoglycolate lyase (PGL) ---first
reported by our laboratory--catalyzes dealdylation of the a-
hydroxyglycine derevatives to produce the final amidated product plus
glyoxylte. Our research program focuses on this carboxly-terminal
amidation inhibitors, inactvator and substrate analogs and to delineate
the role amidative processing in various cellular-level processes such
as vascular function and tumor cell growth.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1042/0264-6021:3500521
发表时间:
2000-09-01
期刊:
BIOCHEMICAL JOURNAL
影响因子:
4.1
作者:
[Feng, J, Shi, J, May, SW]
通讯作者:
May, SW
Reversal of the transformed phenotype and inhibition of peptidylglycine alpha-monooxygenase in Ras-transformed cells by 4-phenyl-3-butenoic acid.
4-苯基-3-丁烯酸逆转 Ras 转化细胞中的转化表型并抑制肽基甘氨酸 α-单加氧酶。
DOI:
10.1002/mc.20060
发表时间:
2004
期刊:
Molecular carcinogenesis.
影响因子:
--
作者:
[Sunman,JeffreyA, Foster,MichaelS, Folse,StaceyL, May,SheldonW, Matesic,DianeF]
通讯作者:
Matesic,DianeF
Pharmacological evaluation of 1-(carboxymethyl)-3,5-diphenyl-2-methylbenzene, a novel arylacetic acid with potential anti-inflammatory properties.
1-(羧甲基)-3,5-二苯基-2-甲基苯的药理学评价,一种具有潜在抗炎特性的新型芳基乙酸。
DOI:
10.1007/s000110050335
发表时间:
1998
期刊:
Inflammation research : official journal of the European Histamine Research Society ... [et al.].
影响因子:
--
作者:
[Cutler,SJ, DeWittBlantonJr,C, Akin,DT, Steinberg,FB, Moore,AB, Lott,JA, Price,TC, May,SW, Pollock,SH]
通讯作者:
Pollock,SH
Reaction versus subsite stereospecificity of peptidylglycine alpha-monooxygenase and peptidylamidoglycolate lyase, the two enzymes involved in peptide amidation.
肽基甘氨酸α-单加氧酶和肽基酰胺乙醇酸裂解酶(这两种参与肽酰胺化的酶)的反应与亚位点立体特异性。
DOI:
10.1074/jbc.270.49.29250
发表时间:
1995
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Ping,D, Mounier,CE, May,SW]
通讯作者:
May,SW
Kinetic and inhibition studies on substrate channelling in the bifunctional enzyme catalysing C-terminal amidation.
双功能酶催化 C 端酰胺化的底物通道动力学和抑制研究。
DOI:
--
发表时间:
1999
期刊:
The Biochemical journal
影响因子:
--
作者:
[Moore,AB, May,SW]
通讯作者:
May,SW
共 11 条
NEUROPEPTIDES--APPROACH TO AMIDATION EFFECTORS
-
批准号:2022242
-
项目类别:
-
资助金额:$24.39万
-
财政年份:1992
-
负责人:SHELDON W MAY
-
依托单位:
NEUROPEPTIDES--APPROACHES TO ALPHA-AMIDATION EFFECTORS
-
批准号:3298182
-
项目类别:
-
资助金额:$21.15万
-
财政年份:1992
-
负责人:SHELDON W MAY
-
依托单位:
NEUROPEPTIDES--APPROACH TO AMIDATION EFFECTORS
-
批准号:2684894
-
项目类别:
-
资助金额:$20.79万
-
财政年份:1992
-
负责人:SHELDON W MAY
-
依托单位:
NEUROPEPTIDES--APPROACHES TO ALPHA-AMIDATION EFFECTORS
-
批准号:3298181
-
项目类别:
-
资助金额:$22.66万
-
财政年份:1992
-
负责人:SHELDON W MAY
-
依托单位:
NEUROPEPTIDES--APPROACHES TO ALPHA-AMIDATION EFFECTORS
-
批准号:2180417
-
项目类别:
-
资助金额:$22.26万
-
财政年份:1992
-
负责人:SHELDON W MAY
-
依托单位:
NEUROPEPTIDES--APPROACHES TO ALPHA-AMIDATION EFFECTORS
-
批准号:2180416
-
项目类别:
-
资助金额:$21.02万
-
财政年份:1992
-
负责人:SHELDON W MAY
-
依托单位:
METALLO MONOOXYGENASE CATALYSIS
-
批准号:3284180
-
项目类别:
-
资助金额:$3.37万
-
财政年份:1987
-
负责人:SHELDON W MAY
-
依托单位:
METALLO MONOOXYGENASE CATALYSIS
-
批准号:3284181
-
项目类别:
-
资助金额:$10.65万
-
财政年份:1985
-
负责人:SHELDON W MAY
-
依托单位:
METALLO MONOOXYGENASE CATALYSIS
-
批准号:3284179
-
项目类别:
-
资助金额:$10.92万
-
财政年份:1985
-
负责人:SHELDON W MAY
-
依托单位:
NON-HEME METALLO OXYGENASE CATALYSTS
-
批准号:3271665
-
项目类别:
-
资助金额:$16.97万
-
财政年份:1984
-
负责人:SHELDON W MAY
-
依托单位:
NON-HEME METALLO OXYGENASE CATALYSTS
-
批准号:3271664
-
项目类别:
-
资助金额:$16.2万
-
财政年份:1984
-
负责人:SHELDON W MAY
-
依托单位:
NON-HEME METALLO OXYGENASE CATALYSTS
-
批准号:3271663
-
项目类别:
-
资助金额:$15.41万
-
财政年份:1984
-
负责人:SHELDON W MAY
-
依托单位:
NOVEL ANTIHYPERTENSIVES: RATIONAL DESIGN AND EVALUATION
-
批准号:3339577
-
项目类别:
-
资助金额:$20.1万
-
财政年份:1982
-
负责人:SHELDON W MAY
-
依托单位:
NOVEL ANTIHYPERTENSIVES: RATIONAL DESIGN AND EVALUATION
-
批准号:3339576
-
项目类别:
-
资助金额:$24.86万
-
财政年份:1982
-
负责人:SHELDON W MAY
-
依托单位:
NOVEL ANTIHYPERTENSIVES: RATIONAL DESIGN AND EVALUATION
-
批准号:3339581
-
项目类别:
-
资助金额:$24.97万
-
财政年份:1982
-
负责人:SHELDON W MAY
-
依托单位:
NOVEL ANTIHYPERTENSIVES: RATIONAL DESIGN AND EVALUATION
-
批准号:2216234
-
项目类别:
-
资助金额:$24.68万
-
财政年份:1982
-
负责人:SHELDON W MAY
-
依托单位:
NOVEL ANTIHYPERTENSIVES: RATIONAL DESIGN AND EVALUATION
-
批准号:3339578
-
项目类别:
-
资助金额:$19.88万
-
财政年份:1982
-
负责人:SHELDON W MAY
-
依托单位:
NOVEL ANTIHYPERTENSIVES: RATIONAL DESIGN AND EVALUATION
-
批准号:3339580
-
项目类别:
-
资助金额:$24.48万
-
财政年份:1982
-
负责人:SHELDON W MAY
-
依托单位:
NOVEL ANTIHYPERTENSIVES: RATIONAL DESIGN AND EVALUATION
-
批准号:3339575
-
项目类别:
-
资助金额:$20.65万
-
财政年份:1982
-
负责人:SHELDON W MAY
-
依托单位:
NOVEL ANTIHYPERTENSIVES: RATIONAL DESIGN AND EVALUATION
-
批准号:3339579
-
项目类别:
-
资助金额:$20.75万
-
财政年份:1982
-
负责人:SHELDON W MAY
-
依托单位:
海外基金